Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03526887
Title Re-challenge Pembrolizumab Study as a Second or Further Line in Patients With Advanced NSCLC (Replay)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Spanish Lung Cancer Group
Indications

lung non-squamous non-small cell carcinoma

lung squamous cell carcinoma

lung non-small cell carcinoma

Therapies

Pembrolizumab

Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital General Universitario de Elche Recruiting Elche Alicante 03203 Spain Details
H. Germans Trias i Pujol Recruiting Badalona Barcelona 08916 Spain Details
Hospital Parc Taulí Recruiting Sabadell Barcelona 08208 Spain Details
Consorci Sanitari de Terrassa Recruiting Terrassa Barcelona 08227 Spain Details
Complejo Hospitalario de la Coruña Recruiting La Coruña Coruña 15006 Spain Details
Clínica Universidad de Navarra Recruiting Pamplona Navarra 31008 Spain Details
Hospital de Basurto Recruiting Bilbao Vizcaya 48013 Spain Details
Hospital de Santa Creu i Sant Pau Recruiting Barcelona 08025 Spain Details
H.U.Vall D´Hebrón Recruiting Barcelona 08035 Spain Details
Hospital Dr. Josep Trueta Recruiting Girona 17007 Spain Details
Complejo Hospitalario de Jaén Recruiting Jaén 23007 Spain Details
Complejo Asistencial Universitario de León Recruiting León 24071 Spain Details
Fundación Jiménez Díaz Recruiting Madrid 28040 Spain Details
H. 12 de Octubre Recruiting Madrid 28041 Spain Details
Puerta de Hierro Recruiting Madrid Spain Details
H. Son Llàtzer Recruiting Palma de Mallorca 07198 Spain Details
Hospital General Universitario de Valencia Recruiting Valencia 46014 Spain Details
Hospital La Fe Recruiting Valencia 46026 Spain Details
Hospital Miguel Servet Recruiting Zaragoza 50009 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field